134 related articles for article (PubMed ID: 31966428)
1. Up-regulation of the tumor promoter Glyoxalase-1 indicates poor prognosis in breast cancer.
Peng HT; Chen J; Liu TY; Wu YQ; Lin XH; Lai YH; Huang YF
Int J Clin Exp Pathol; 2017; 10(11):10852-10862. PubMed ID: 31966428
[TBL] [Abstract][Full Text] [Related]
2. High expression of GLO1 indicates unfavorable clinical outcomes in glioma patients.
Tian X; Wang Y; Ding X; Cheng W
J Neurosurg Sci; 2022 Jun; 66(3):228-233. PubMed ID: 31738028
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of Wnt7b rather than Wnt1, Wnt7a, and Wnt9a indicates poor prognosis in breast cancer.
Chen J; Liu TY; Peng HT; Wu YQ; Zhang LL; Lin XH; Lai YH
Int J Clin Exp Pathol; 2018; 11(9):4552-4561. PubMed ID: 31949853
[TBL] [Abstract][Full Text] [Related]
4. Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression.
Cheng WL; Tsai MM; Tsai CY; Huang YH; Chen CY; Chi HC; Tseng YH; Chao IW; Lin WC; Wu SM; Liang Y; Liao CJ; Lin YH; Chung IH; Chen WJ; Lin PY; Wang CS; Lin KH
PLoS One; 2012; 7(3):e34352. PubMed ID: 22479608
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
6. Glyoxalase 1 gene is highly expressed in basal-like human breast cancers and contributes to survival of ALDH1-positive breast cancer stem cells.
Tamori S; Nozaki Y; Motomura H; Nakane H; Katayama R; Onaga C; Kikuchi E; Shimada N; Suzuki Y; Noike M; Hara Y; Sato K; Sato T; Yamamoto K; Hanawa T; Imai M; Abe R; Yoshimori A; Takasawa R; Tanuma SI; Akimoto K
Oncotarget; 2018 Nov; 9(92):36515-36529. PubMed ID: 30559934
[TBL] [Abstract][Full Text] [Related]
7. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
8. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
9. Exploring glyoxalase 1 expression in prostate cancer tissues: targeting the enzyme by ethyl pyruvate defangs some malignancy-associated properties.
Baunacke M; Horn LC; Trettner S; Engel KM; Hemdan NY; Wiechmann V; Stolzenburg JU; Bigl M; Birkenmeier G
Prostate; 2014 Jan; 74(1):48-60. PubMed ID: 24105621
[TBL] [Abstract][Full Text] [Related]
10. Glyoxalase I (GLO1) is up-regulated in pancreatic cancerous tissues compared with related non-cancerous tissues.
Wang Y; Kuramitsu Y; Ueno T; Suzuki N; Yoshino S; Iizuka N; Akada J; Kitagawa T; Oka M; Nakamura K
Anticancer Res; 2012 Aug; 32(8):3219-22. PubMed ID: 22843895
[TBL] [Abstract][Full Text] [Related]
11. Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome.
Alhujaily M; Abbas H; Xue M; de la Fuente A; Rabbani N; Thornalley PJ
Front Oncol; 2021; 11():748698. PubMed ID: 34790575
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer proteomics reveals a positive correlation between glyoxalase 1 expression and high tumor grade.
Fonseca-Sánchez MA; Rodríguez Cuevas S; Mendoza-Hernández G; Bautista-Piña V; Arechaga Ocampo E; Hidalgo Miranda A; Quintanar Jurado V; Marchat LA; Alvarez-Sánchez E; Pérez Plasencia C; López-Camarillo C
Int J Oncol; 2012 Aug; 41(2):670-80. PubMed ID: 22614840
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
[TBL] [Abstract][Full Text] [Related]
15. Genetic Target Modulation Employing CRISPR/Cas9 Identifies Glyoxalase 1 as a Novel Molecular Determinant of Invasion and Metastasis in A375 Human Malignant Melanoma Cells In Vitro and In Vivo.
Jandova J; Perer J; Hua A; Snell JA; Wondrak GT
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32466621
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
17. Glyoxalase I in tumor cell proliferation and survival and as a potential target for anticancer therapy.
Geng X; Ma J; Zhang F; Xu C
Oncol Res Treat; 2014; 37(10):570-4. PubMed ID: 25342507
[TBL] [Abstract][Full Text] [Related]
18. Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells.
Sakamoto H; Mashima T; Sato S; Hashimoto Y; Yamori T; Tsuruo T
Clin Cancer Res; 2001 Aug; 7(8):2513-8. PubMed ID: 11489834
[TBL] [Abstract][Full Text] [Related]
19. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
